BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38039876)

  • 21. Extranodal extension is a strong prognosticator in HPV-positive oropharyngeal squamous cell carcinoma.
    Bauer E; Mazul A; Chernock R; Rich J; Jackson RS; Paniello R; Pipkorn P; Oppelt P; Gay H; Daly M; El-Mofty S; Thorstad W; Adkins D; Zevallos J
    Laryngoscope; 2020 Apr; 130(4):939-945. PubMed ID: 31077394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Race and Insurance Status on Primary Treatment for HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
    Habib AM; Carey RM; Prasad A; Mady LJ; Shinn JR; Bur AM; Brody RM; Cannady SB; Rajasekaran K; Ibrahim SA; Newman JG; Brant JA
    Otolaryngol Head Neck Surg; 2022 Jun; 166(6):1062-1069. PubMed ID: 34253112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of p16 expression, nodal status, and smoking on oncologic outcomes of patients with head and neck unknown primary squamous cell carcinoma.
    Dixon PR; Au M; Hosni A; Perez-Ordonez B; Weinreb I; Xu W; Song Y; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
    Head Neck; 2016 Sep; 38(9):1347-53. PubMed ID: 27002481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex-based differences in outcomes of patients with HPV-positive versus HPV-negative oropharyngeal carcinoma: a population-based study.
    Abdel-Rahman O
    Expert Rev Anticancer Ther; 2020 Sep; 20(9):813-818. PubMed ID: 32787745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytology and direct human papillomavirus testing on fine needle aspirates from cervical lymph node metastases of patients with oropharyngeal squamous cell carcinoma or occult primary.
    Rollo F; Dona' MG; Pellini R; Pichi B; Marandino F; Covello R; Benevolo M
    Cytopathology; 2018 Oct; 29(5):449-454. PubMed ID: 29873841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.
    Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papillomavirus testing in metastatic squamous cell carcinoma of the neck with unknown primary using PCR on fine-needle aspiration smears: a prospective clinical study.
    Channir HI; Lomholt AF; Gerds TA; Charabi BW; Kiss K; von Buchwald C
    Eur Arch Otorhinolaryngol; 2022 Jun; 279(6):3115-3121. PubMed ID: 34689237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying an oligometastatic phenotype in HPV-associated oropharyngeal squamous cell cancer: Implications for clinical trial design.
    Fleming CW; Ward MC; Woody NM; Joshi NP; Greskovich JF; Rybicki L; Xiong D; Contrera K; Chute DJ; Milas ZL; Frenkel CH; Brickman DS; Carrizosa DR; Ku J; Prendes B; Lamarre E; Lorenz RR; Scharpf J; Burkey BB; Schwartzman L; Geiger JL; Adelstein DJ; Koyfman SA
    Oral Oncol; 2021 Jan; 112():105046. PubMed ID: 33129058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Staging and treatment of oropharyngeal cancer in the human papillomavirus era.
    Ward MJ; Mellows T; Harris S; Webb A; Patel NN; Cox HJ; Piper K; Ottensmeier CH; Thomas GJ; King EV
    Head Neck; 2015 Jul; 37(7):1002-13. PubMed ID: 24753272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Socioeconomic Factors Influence the Impact of Tumor HPV Status on Outcome of Patients With Oropharyngeal Squamous Cell Carcinoma.
    Marks JA; Switchenko JM; Steuer CE; Ryan M; Patel MR; McDonald MW; Higgins K; Beitler JJ; Shin DM; Gillespie TW; Saba NF
    JCO Oncol Pract; 2021 Mar; 17(3):e313-e322. PubMed ID: 33434083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Independent association of marijuana use and poor oral hygiene with HPV-negative but not HPV-positive head and neck squamous cell carcinomas.
    Shewale JB; Pickard RKL; Xiao W; Jiang B; Gillison ML
    Cancer; 2021 Jun; 127(12):2099-2110. PubMed ID: 33620741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of human papillomavirus status on prognosis and local treatment strategies of T1-2N0 oropharyngeal squamous cell cancer.
    Zhou P; Chen DL; Lian CL; Wu SG; Zhang SY
    Front Public Health; 2022; 10():900294. PubMed ID: 35958856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Incidence, Survival, and HPV Impact of Second Primary Cancer following Primary Oropharyngeal Squamous Cell Carcinoma: A 20-Year Retrospective and Population-Based Study.
    Andersen L; Jakobsen KK; Carlander AF; Garset-Zamani M; Friborg J; Kiss K; Marvig RL; Olsen C; Nielsen FC; Andersen E; Grønhøj C; Buchwald CV
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DETECTION OF HUMAN PAPILLOMA VIRUS IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS: A LITERATURE REVIEW.
    Jelihovschi I; Bidescu AC; Tucaliuc SE; Iancu LS
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):502-9. PubMed ID: 26204659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human Immunodeficiency Virus Is Associated With Poor Overall Survival Among Patients With Head and Neck Cancer.
    Salahuddin S; Cohen O; Wu M; Perez Irizarry J; Vega T; Gan G; Deng Y; Isaeva N; Prasad M; Schalper KA; Mehra S; Yarbrough WG; Emu B
    Clin Infect Dis; 2023 Apr; 76(8):1449-1458. PubMed ID: 36520995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of HPV16/18 E6 Oncoproteins in Head and Neck Squamous Cell Carcinoma Using a Protein Immunochromatographic Assay.
    Menegaldo A; Schroeder L; Holzinger D; Tirelli G; Dal Cin E; Tofanelli M; Rigo S; Mantovani M; Stellin M; Del Mistro A; Dei Tos AP; Guerriero A; Niero M; Borsetto D; Da Mosto MC; Polesel J; Pawlita M; Waterboer T; Boscolo-Rizzo P
    Laryngoscope; 2021 May; 131(5):1042-1048. PubMed ID: 33103777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p16 status, pathologic and clinical characteristics, biomolecular signature, and long-term outcomes in head and neck squamous cell carcinomas of unknown primary.
    Keller LM; Galloway TJ; Holdbrook T; Ruth K; Yang D; Dubyk C; Flieder D; Lango MN; Mehra R; Burtness B; Ridge JA
    Head Neck; 2014 Dec; 36(12):1677-84. PubMed ID: 24115269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human papillomavirus in head and neck squamous cell carcinoma of unknown primary is a common event and a strong predictor of survival.
    Jensen DH; Hedback N; Specht L; Høgdall E; Andersen E; Therkildsen MH; Friis-Hansen L; Norrild B; von Buchwald C
    PLoS One; 2014; 9(11):e110456. PubMed ID: 25369118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p16-positive lymph node metastases from cutaneous head and neck squamous cell carcinoma: No association with high-risk human papillomavirus or prognosis and implications for the workup of the unknown primary.
    McDowell LJ; Young RJ; Johnston ML; Tan TJ; Kleid S; Liu CS; Bressel M; Estall V; Rischin D; Solomon B; Corry J
    Cancer; 2016 Apr; 122(8):1201-8. PubMed ID: 26881928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.